Topic: Bapineuzumab

New medical guidelines reclassify Alzheimer's into three stages, including a "pre-symptomatic" phase where patients show no outward signs of memory loss. The hosts argue this is a public relations campaign by the pharmaceutical industry to expand the market for upcoming vaccines like Bapineuzumab. They suggest the goal is to "ratchet down" dementia criteria so that healthy individuals can be medicated preventatively.